Synlogic, Inc. (NASDAQ: SYBX) is a clinical-stage biotechnology company developing medicines for metabolic and immunological diseases through its proprietary approach to synthetic biology.
Headquarters | Cambridge, MA |
Website | www.synlogictx.com |
@synlogic_tx | |
Pipeline | Phase 2 clinical trials |
Partners | AbbVie |